Optogenetics sheds light on cardiotoxicity screening for new drugs
Researchers from the George Washington University (Washington D.C., USA) have developed an optogenetic technique for testing the cardiotoxicity of new drugs for heart arrhythmias.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.